Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Dalerba

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 19, 2007
The prognostic role of a gene signature from tumorigenic breast-cancer cellsRui Liu, Xinhao Wang, Grace Y Chen, et al.
Journal of the National Cancer Institute|April 11, 2023
Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinomaSara Viragova, Luis Aparicio, Pierangela Palmerini, et al.
EMBO Reports|March 6, 2019
<i>Fusobacterium nucleatum</i> promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1Mara Roxana Rubinstein, Jung Eun Baik, Stephen M Lagana, et al.
Cancer Research|August 9, 2003
The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patientsChiara Casati, Piero Dalerba, Licia Rivoltini, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to <i>irinotecan</i> (CPT-11)Junichi Matsubara, Yong Fuga Li, Sanjay Koul, et al.
Nature Methods|October 22, 2013
Quantitative assessment of single-cell RNA-sequencing methodsAngela R Wu, Norma F Neff, Tomer Kalisky, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 11, 2022
Therapeutic Nanocarriers Inhibit Chemotherapy-Induced Breast Cancer MetastasisTianyu Li, Tolulope Akinade, Jie Zhou, et al.
Cancer Research|October 30, 2003
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigenMonica Rodolfo, Roberto Luksch, Elisabeth Stockert, et al.
Cancer Research|August 17, 2019
miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem CellsJunko Mukohyama, Taichi Isobe, Qingjiang Hu, et al.
Gastroenterology|February 16, 2012
Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in miceMichael E Rothenberg, Ysbrand Nusse, Tomer Kalisky, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 19, 2007
The prognostic role of a gene signature from tumorigenic breast-cancer cellsRui Liu, Xinhao Wang, Grace Y Chen, et al.
Journal of the National Cancer Institute|April 11, 2023
Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinomaSara Viragova, Luis Aparicio, Pierangela Palmerini, et al.
EMBO Reports|March 6, 2019
<i>Fusobacterium nucleatum</i> promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1Mara Roxana Rubinstein, Jung Eun Baik, Stephen M Lagana, et al.
Cancer Research|August 9, 2003
The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patientsChiara Casati, Piero Dalerba, Licia Rivoltini, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to <i>irinotecan</i> (CPT-11)Junichi Matsubara, Yong Fuga Li, Sanjay Koul, et al.
Nature Methods|October 22, 2013
Quantitative assessment of single-cell RNA-sequencing methodsAngela R Wu, Norma F Neff, Tomer Kalisky, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 11, 2022
Therapeutic Nanocarriers Inhibit Chemotherapy-Induced Breast Cancer MetastasisTianyu Li, Tolulope Akinade, Jie Zhou, et al.
Cancer Research|October 30, 2003
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigenMonica Rodolfo, Roberto Luksch, Elisabeth Stockert, et al.
Cancer Research|August 17, 2019
miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem CellsJunko Mukohyama, Taichi Isobe, Qingjiang Hu, et al.
Gastroenterology|February 16, 2012
Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in miceMichael E Rothenberg, Ysbrand Nusse, Tomer Kalisky, et al.
Pageof 5